Literature DB >> 6202124

Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.

P M Epstein, R Hachisu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202124

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res        ISSN: 0747-7767


× No keyword cloud information.
  13 in total

1.  Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.

Authors:  P M Epstein; S Moraski; R Hachisu
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme.

Authors:  S Lal; R V Raju; R K Sharma
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

Review 4.  PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.

Authors:  Anindita Das; David Durrant; Fadi N Salloum; Lei Xi; Rakesh C Kukreja
Journal:  Pharmacol Ther       Date:  2014-10-31       Impact factor: 12.310

5.  Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts.

Authors:  M Peracchi; F Bamonti-Catena; B Bareggi; R Calori; A T Maiolo
Journal:  Blut       Date:  1990-03

6.  Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.

Authors:  J E Souness; C Maslen; S Webber; M Foster; D Raeburn; M N Palfreyman; M J Ashton; J A Karlsson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Time-course changes in content and fatty acid composition of phosphatidic acid from rat thymocytes during concanavalin A stimulation.

Authors:  S el Bawab; O Macovschi; M Lagarde; A F Prigent
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.

Authors:  X Jiang; J Li; M Paskind; P M Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Safety and Pharmacodynamics of the PDE4 Inhibitor Roflumilast in Advanced B-cell Malignancies.

Authors:  Kevin Kelly; Alex Mejia; Avvaru N Suhasini; An-Ping Lin; John Kuhn; Anand B Karnad; Steven Weitman; Ricardo C T Aguiar
Journal:  Clin Cancer Res       Date:  2016-08-19       Impact factor: 12.531

10.  The interaction of (1-4)-fragment of thymosin beta 4 with calmodulin-sensitive cAMP phosphodiesterase from hypothalamus.

Authors:  W Voelter; A Kapuzniotu; M Mihelic; B Gurvits; G Abrahamian; A Galoyan
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.